Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1978-08-28
1980-09-16
Padgett, Benjamin R.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
260112B, 424 12, 424177, G01N 3316, A61K 4300, C07G 700
Patent
active
042230020
ABSTRACT:
A method of isolating alpha.sub.1 -fetoprotein sufficiently pure to be useful in radioimmunoassay procedures is described. The method comprises the procedures and techniques of affinity chromatography, immobilized reactive dye adsorption chromatography and polyacrylamide gel electrophoresis. Wherein a certain degree of reduction in kind and/or quantity of contaminants is not achieved by the first two procedures, gel filtration and mixed ion exchange cellulose chromatography are carried out in preparation for polyacrylamide gel electrophoresis. Monkey alpha.sub.1 -fetoprotein very similar to human cord blood alpha.sub.1 -fetoprotein by amino acid composition and physical properties and of sufficient purity to be useful in human radioimmunoassay procedures is obtained by the disclosed method.
Gould George M.
Hoffmann-La Roche Inc.
Nucker Christine M.
Padgett Benjamin R.
Saxe Jon S.
LandOfFree
Isolation of alpha.sub.1 -fetoprotein does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Isolation of alpha.sub.1 -fetoprotein, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isolation of alpha.sub.1 -fetoprotein will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-540634